Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) must be stored in a refrigerator between 2°C and 8°C, but the official SmPC does allow a limited period at room temperature once removed. Exactly how long that window lasts (and what counts as safe room temperature) is specified in the Mounjaro SmPC on the eMC, and that document is the authority you should check rather than any online estimate. What the evidence and manufacturer guidance make clear is that the window is finite: leaving a pen out indefinitely, or exposing it to heat, risks degrading the medicine before you inject it. The tirzepatide treatment overview has context on how the medicine works and what affects its efficacy. This page explains the storage rules, what to do if you have a concern, and when to speak to a prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Summary of Product Characteristics for Mounjaro, published on the Electronic Medicines Compendium and authorised by the MHRA, is the definitive document for storage conditions. It specifies both the maximum temperature and the maximum duration a pen may be kept outside refrigeration. Those exact figures are not repeated here, because SmPC wording can be updated and any static copy risks becoming outdated; the eMC listing for tirzepatide is the live, accurate version.
What the guidance consistently establishes is a short, bounded window, not an indefinite one. Room temperature in the context of medicine storage means something more precise than most people assume. If your kitchen runs warm in summer, or a pen has been sitting near a radiator, the effective safe period may already be compromised even if the clock still has hours to run. The NHS patient information page on tirzepatide also covers storage in plain language and is worth bookmarking alongside the leaflet that comes with your pen.
One practical detail many people miss: the KwikPen is a multi-dose device. Each pen contains four weekly doses. Correct storage across the whole month matters, not just for the first injection. A pen that has been mishandled mid-way through its doses presents the same degradation risk as one left out from day one.
Tirzepatide is a large-molecule peptide. Like most peptides used in injectable medicines, it is sensitive to temperature excursions. Exposure to temperatures above the permitted ceiling, or duration beyond the allowed window, can cause the protein structure to break down in ways that are invisible to the naked eye. The liquid in the pen will look the same (clear and colourless) whether it is intact or degraded.
This is why the instruction to inspect the pen before each injection matters. The SmPC and Patient Information Leaflet both state that the solution should be clear, colourless to slightly yellow, and free of particles. If it appears cloudy, discoloured, or contains visible particles, do not use it. That visual check is a basic safety step, but it will not catch every form of degradation caused by temperature. A pen that looks fine may still have reduced potency if it has been stored incorrectly.
The practical implication: if you are unsure whether a pen has been out for too long, contact your prescriber or pharmacist rather than injecting and hoping. Reduced potency means reduced therapeutic effect, the opposite of what your treatment plan is aiming for. There is more detail on what to do when a Mounjaro pen has been left out if you need to assess a specific situation.
Most storage problems come down to routine rather than carelessness. A pen moved to a handbag for a weekend away and forgotten. A box left on the kitchen counter after delivery while other shopping was unpacked. A pen placed in the fridge door (the part of the fridge that fluctuates most with opening and closing) rather than further back on a shelf where temperatures stay steadier.
Travel is the scenario our prescribers hear about most often. Taking Mounjaro on holiday, through airport security, and into hotel rooms with variable air conditioning raises genuine storage questions that are worth thinking through before departure, not the night before your injection. The pen must not be frozen, so it should not go in checked luggage in an aircraft hold or in a hotel mini-bar that runs very cold. Insulated cool bags can help for travel, but if you want to understand how long Mounjaro can be out of the fridge in practical terms, the SmPC's room-temperature window applies here too, and you are not extending it by keeping the pen in a bag rather than a fridge.
If your injection day and timing questions go beyond storage (for example, whether morning or evening injections affect tolerability) the guidance on injection timing covers that separately. For a closer look at the permitted out-of-fridge duration in specific terms, the full breakdown of the time window is a useful companion to this page.
Storage queries that feel straightforward (a pen left out for a few hours at a cool room temperature) are usually answerable by checking the Patient Information Leaflet against the duration and temperature. Queries that are less clear-cut warrant a conversation with a prescriber or pharmacist. These include: a pen that was left in a warm car or direct sunlight; a pen that was accidentally frozen and then thawed; a pen whose storage history across the full month is uncertain; or any situation where you have already injected from a pen and are now questioning the storage conditions for the remaining doses.
In those cases, the appropriate step is to pause and get advice rather than continue. A prescriber can help you decide whether the pen should be discarded and a replacement arranged. There is no clinical benefit to injecting from a potentially degraded pen, and the decision should not rest solely on the clock. Our Mounjaro injection guide covers correct technique and site rotation, which works alongside proper storage to ensure each dose is as effective as it can be.
If you are considering starting tirzepatide treatment or have questions about storage and clinical suitability as part of your consultation, speaking to our prescribers is the right starting point. Every consultation at nume is reviewed by a GPhC-registered prescriber on the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.